Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...

A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

The pharmaceutical industry is staring down a major patent cliff, with key drugs from Merck (MRK), Bristol Myers Squibb (BMY), and Johnson & Johnson (JNJ) set to lose exclusivity by 2030. Yahoo ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

A nurse who helped lead early clinical trials of Viagra and later played a key role in the Covid-19 research response speaks ...

Ursula von der Leyen, the EU’s most powerful official, coasted to victory after a no-confidence vote on Thursday. Some of her ...

RFK Jr. cancels U.S. Preventive Services Task Force meeting; the Department of Health and Human Services backtracked on its claim that it would release ethics forms for new members of the Advisory ...

Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.

Cypriot members of the European parliament were evenly split over a no-confidence vote in European Commission President Ursula von der Leyen, with two voting in favour, two voting against, and two not ...